Work

Phase-3 study of vamotinib (PF-114) versus high-dose imatinib

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7290

Authors: Anna Turkina, Olga Vinogradova, Nuriya Kalimulina, Tatyana Shelekhova, Igor Davydkin, Bulat Bakirov, Tatiana Pospelova, Elza Lomaia, Jitendra Pehalajani, Vishvdeep Khushoo, Shashikant Apte, Robert Gale, Ghermes Chilov

Institutions: National Medical Research Center for Hematology, Botkin Hospital, Samara State Medical University, Bashkir State Medical University, Novosibirsk State Medical University, Federal Almazov North-West Medical Research Centre, All India Institute of Medical Sciences, Nagpur, Imperial College London, Russian Space Systems

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417005223

Cites:

Cited by:

Related to: